Table 1.
Demographics and Prevalence of Underlying Medical Conditions by Age Group
| Variable | All Adults (N = 10 679 566) |
18–49 y (n = 3 922 320) |
50–64 y (n = 2 214 490) |
65–74 y (n = 2 446 888) |
≥75 y (n = 2 095 868) |
|---|---|---|---|---|---|
| Male, No. (%) | 5 064 018 (47.4) | 2 023 066 (51.6) | 1 106 165 (50.0) | 1 075 516 (44.0) | 859 271 (41.0) |
| Race/ethnicity, No. (%) | |||||
| Asian | 451 943 (4.2) | 231 066 (5.9) | 73 731 (3.3) | 79 471 (3.2) | 67 675 (3.2) |
| Black | 903 450 (8.5) | 324 547 (8.3) | 195 522 (8.8) | 206 373 (8.4) | 177 008 (8.4) |
| Hispanic | 1 177 678 (11.0) | 516 025 (13.2) | 228 236 (10.3) | 222 376 (9.1) | 211 041 (10.1) |
| White | 6 053 817 (56.7) | 2 102 240 (53.6) | 1 350 883 (61.0) | 1 290 418 (52.7) | 1 310 276 (62.5) |
| Unknown | 2 092 678 (19.6) | 748 442 (19.1) | 366 118 (16.5) | 648 250 (26.5) | 329 868 (15.7) |
| Underlying medical condition, No. (%) | |||||
| Asthma | 331 849 (3.1) | 77 603 (2.0) | 77 373 (3.5) | 98 339 (4.0) | 78 534 (3.7) |
| Cerebrovascular disease | 319 155 (3.0) | 8369 (0.2) | 39 880 (1.8) | 101 554 (4.2) | 169 352 (8.1) |
| Cardiovascular disease | 4 005 853 (37.5) | 309 735 (7.9) | 786 127 (35.5) | 1 415 327 (57.8) | 1 494 664 (71.3) |
| Chronic kidney disease | 874 032 (8.2) | 27 655 (0.7) | 100 337 (4.5) | 282 112 (11.5) | 463 928 (22.1) |
| Chronic liver disease | 208 343 (2.0) | 31 640 (0.8) | 59 589 (2.7) | 74 762 (3.1) | 42 352 (2.0) |
| COPD | 565 015 (5.3) | 15 922 (0.4) | 99 884 (4.5) | 202 385 (8.3) | 246 824 (11.8) |
| Diabetes | 1 560 803 (14.6) | 110 866 (2.8) | 323 734 (14.6) | 593 094 (24.2) | 533 109 (25.4) |
| Hypertension | 3 528 192 (33.0) | 247 976 (6.3) | 688 268 (31.1) | 1 260 468 (51.5) | 1 331 480 (63.5) |
| Malignancy | 823 902 (7.7) | 40 474 (1.0) | 135 473 (6.1) | 291 063 (11.9) | 356 892 (17.0) |
| Neurologic disease | 365 094 (3.4) | 28 969 (0.7) | 44 678 (2.0) | 75 200 (3.1) | 216 247 (10.3) |
| Obesity | 1 033 588 (9.7) | 226 294 (5.8) | 281 309 (12.7) | 336 429 (13.7) | 189 556 (9.0) |
| Rheumatic disease | 245 576 (2.3) | 39 295 (1.0) | 65 193 (2.9) | 77 890 (3.2) | 63 198 (3.0) |
| Smoking history | 741 474 (6.9) | 87 314 (2.2) | 173 726 (7.8) | 251 871 (10.3) | 228 563 (10.9) |
| SARS-CoV-2 outcome, No. (%) | |||||
| COVID-19 diagnosis | 391 964 (3.7) | 132 094 (3.4) | 82 921 (3.7) | 81 421 (3.3) | 95 528 (4.6) |
| Hospitalization | 87 526 (0.8) | 5589 (0.1) | 12 565 (0.6) | 24 904 (1.0) | 44 468 (2.1) |
| Length of stay, d, median (Q1, Q3) | 7 (4, 15) | 5 (3, 8) | 6 (4, 12) | 7 (4, 15) | 8 (5, 16) |
| ICU admission | 41 533 (0.4) | 2653 (0.1) | 6757 (0.3) | 13 065 (0.5) | 19 058 (0.9) |
| Intubation and MV or ECMO | 12 758 (0.1) | 612 (0.0) | 2292 (0.1) | 4624 (0.2) | 5230 (0.2) |
| Diagnosed and died | 35 388 (0.3) | 419 (0.0) | 2359 (0.1) | 7891 (0.3) | 24 719 (1.2) |
| Hospitalized and died | 26 640 (0.2) | 308 (0.0) | 1915 (0.1) | 6359 (0.3) | 18 058 (0.9) |
| Died the same month as discharge month | 17 899 (0.2) | 222 (0.0) | 1349 (0.1) | 4492 (0.2) | 11 836 (0.6) |
| Died the month after discharge month | 4204 (0.0) | 28 (0.0) | 266 (0.0) | 838 (0.0) | 3072 (0.1) |
| Died ≥2 months after discharge month | 4537 (0.0) | 58 (0.0) | 300 (0.0) | 1029 (0.0) | 3150 (0.2) |
Only the month of death was available.
Abbreviations: COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; MV, mechanical ventilation; Q, quartile; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.